Patents
Patents for C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
04/2008
04/08/2008US7354914 1-[3-Methyl-1-(5-methyl-6-oxo-benzo[b]-1,4-oxazepin-7-ylcarbamoyl)-butyl]-cyclohexanecarboxylic acid amide; inhibit processing of amyloid precursor protein (production of A beta -peptide); neurological disorders related to beta -amyloid production: Alzheimer's disease, Down's Syndrome
04/02/2008EP1905760A1 Process for production of optically active aminopentane derivative, intermediate in the process and process for production of the intermediate
03/2008
03/27/2008US20080076919 of sulfonation cyclization technique for synthesizing acesulfame potassium for continuous production without stirring and special equipment for this technique. An injection pump is adopted to directly inject the sulfonation raw material and sulfonating agent into autoclave for sulfonation cyclization
03/20/2008US20080070885 disorders related to beta-amyloid such as Alzheimer's disease, Down's Syndrome, memory and cognitive impairment, dementia, amyloidosis; (2R,4S) N-Butyl-4-hydroxy-2-methyl-4-((10S,13S)-10-methyl-8,11-dioxo-2-oxa-9,12-diaza-bicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-13-yl)-butyramide for example
03/19/2008EP1654241B1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof
03/19/2008CN101147063A 5-fluoro-uracil immunoassay
03/18/2008CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides
02/2008
02/28/2008US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents
02/21/2008US20080045713 Tetrahydroisoquinolinedione derivative intermediates for the hemisynthesis of ecteinascidin or other tetrahydroisoquinolinephenol compounds
02/20/2008CN101125137A Pharmaceutical salts
02/20/2008CN100369905C Antibiotic & antifouling oxathiazine and its oxide
02/19/2008US7332610 Chemical intermediates for production of sibutramine
02/14/2008US20080039327 3-heterocyclyl-substituted benzoyl derivatives
02/07/2008WO2008016100A1 Method for producing 3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide compound or salt thereof
02/07/2008WO2008016099A1 Method for producing potassium salt of 3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide compound
02/05/2008US7326695 Anti-bacterial agents based upon oxoanion binding
02/05/2008US7326511 chemically amplified photoresist comprising compounds which cures upon the action of an acid or whose solubility is increased upon the action of an acid and photosensitive acid generators; give high resolution with good resist profile
01/2008
01/29/2008US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
01/29/2008US7323571 Heterodimeric dye composition
01/16/2008EP1562918B1 Substituted benzoxazinones and uses thereof
01/10/2008WO2007123853A3 Five-membered heterocyclic invertebrate pest control agents
01/09/2008EP1129064B1 Transfection reagents
01/01/2008US7314930 Reducing 2-nitro-2'-carboxy-diphenylsulfide derivative in presence of hydrogen gas and reduction catalyst; subjecting 2-amino-2'-carboxy-diphenylsulfide derivative to dehydration-condensation to produce dibenzo[b,f][1,4]thiazepin-11-one compound
12/2007
12/26/2007CN100356916C Pharmaceutical compositions
12/25/2007US7312208 Quaternary ammonium compounds
12/20/2007US20070293682 Methods of Preparing Sulfinamides and Sulfoxides
12/19/2007CN101090894A Macrocyclic compounds and compositions useful as BACE inhibitors
12/05/2007CN100352431C Pharmaceutical salts
11/2007
11/29/2007WO2007038512A3 Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/27/2007US7301028 Mitotic kinesin inhibitors
11/22/2007WO2007053650A3 Diazonamide a analog
10/2007
10/24/2007EP1846763A2 5-fluoro-uracil immunoassay
10/17/2007EP1742909A4 Anionic-sweetener-based ionic liquids and methods of use thereof
10/03/2007EP1838680A2 Macrocyclic compounds and compositions useful as bace inhibitors
09/2007
09/19/2007CN200949088Y Special device for hydrolyzing process of synthesizing potassium acetylsulfamilate
09/19/2007CN100338073C Substituted phenylacetic acids
09/12/2007CN200946134Y Special device for Sulphonation ring closure process of synthesizing potassium acetylsulfamilate
09/05/2007EP1829856A2 Transfection reagents
08/2007
08/30/2007US20070203115 Novel quaternary ammonium compounds
08/30/2007US20070202600 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
08/30/2007US20070202598 New transfection reagents
08/21/2007US7259258 Methods of attaching biological compounds to solid supports using triazine
08/21/2007CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
08/14/2007US7256297 Methods of preparing sulfinamides and sulfoxides
07/2007
07/24/2007US7247629 Antitumoral analogs of et-743
07/10/2007US7241897 Process for preparing cyanine dye labeling reagents
07/10/2007US7241892 Hemisynthetic method and new compounds
06/2007
06/27/2007EP1311264B1 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom
06/20/2007CN1321987C Oligomer with double-azo butter-fly shaped rigid large ring, and its prepn. method
06/19/2007US7232792 3-heterocyclyl-substituted benzoyl derivatives
06/14/2007WO2007030582A3 Acyclic ikur inhibitors
06/13/2007EP1794137A2 Specific kinase inhibitors
05/2007
05/29/2007US7223870 Coupling with ligand such as ethylenediamine, diaminocyclohexane
05/16/2007CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof
05/10/2007CA2628026A1 Diazonamide a analog
05/08/2007US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
05/08/2007US7214538 fluoro or chromoionophore based on the covalent linkage of a fluoro or chromophore to an aza-crown-3 calix[4]arene ionophore; facilitating the treatment of various diseases, such as manic-depressive illness
05/01/2007US7211592 Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom
04/2007
04/26/2007WO2006086208A3 5-fluoro-uracil immunoassay
04/18/2007CN1948296A Continuous drying method of potassium acetyl sulfanilate crystal
04/17/2007US7205334 vacuolar-type (H+)-ATPase-inhibiting macrocyclic lactams belonging to the chondropsin class useful in cancer chemotherapy
04/11/2007EP1207868B1 Pharmaceutical tramadol salts
04/11/2007CN1944430A Anti-cancer active compound depside peptide as derivative of natural product
04/10/2007US7202361 Antitumoral ecteinascidin derivatives
04/03/2007CA2163174C Hindered aromatic ester compounds useful as anti-viral agents
03/2007
03/27/2007CA2169145C Substituted benzisoxazole and benzisothiazole herbicidal agents
03/14/2007CN1927850A Sulphonation ring closure process of synthesizing potassium acetylsulfamilate and special device for the same
03/14/2007CN1927849A Hydrolysis process of synthesizing potassium acetylsulfamilate and special device for the same
03/13/2007CA2274756C Methods and pharmaceutical compositions for inhibiting tumour cell growth
03/13/2007CA2264063C Cryptophycin compounds
03/08/2007US20070054883 Use controlling growth of quorum-sensing bacteria, controlling biofilm formation, including biofilm growth; cyclic borate, phosphate or sulfate compounds
03/08/2007US20070054022 Method for the production of a sweetener salt based on aspartame and acesulfame
03/01/2007WO2007024717A2 Agents for preventing and treating disorders involving modulation of the ryr receptors
03/01/2007US20070049759 Methods for Preparing N-Arylated Oxazolidinones Via A Copper Catalyzed Cross Coupling
03/01/2007US20070049572 4-(Piperidinomethylaminosulfonyl),7-(methoxy-)-1,4-benzothiazepineprepared by the reaction of 7-(methoxy-)-1,4-benzothiazepine andpiperidinomethylaminosulfonyl chloride using a basic catalyst; ranodinereceptors that regulate calcium channel functioning in cells; skeletal muscular, cardiac disorders
03/01/2007CA2620183A1 Agents for preventing and treating disorders involving modulation of the ryr receptors
02/2007
02/06/2007US7173154 Transfection reagents
01/2007
01/23/2007US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
01/17/2007EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof
01/09/2007CA2394720C Cyanomethylene compounds and fungicidal compositions
01/04/2007WO2007001015A1 Process for production of optically active aminopentane derivative, intermediate in the process and process for production of the intermediate
01/04/2007CA2612290A1 Process for preparing optically active aminopentane derivative, intermediate and process for preparing intermediate
01/03/2007EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides
12/2006
12/21/2006WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof
12/21/2006US20060287539 Chemical intermediates for production of sibutramine
12/05/2006US7145039 Transfection reagents
11/2006
11/28/2006US7141562 Central nervous system disorders; Parkinson's disease; Huntington's diseases; antidepressants; anxiolytic agents
11/21/2006US7138483 Monomers, conjugated polymers and electronic devices using such polymers
11/07/2006US7132295 Isotopically coded affinity markers 3
11/02/2006EP1716153A2 Methods, compositions, and apparatuses for forming macrocyclic compounds
10/2006
10/31/2006US7129378 Method of preparing amine stereoisomers
10/26/2006WO2006036941A3 Specific kinase inhibitors
10/25/2006EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm
10/05/2006US20060223745 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof
09/2006
09/28/2006WO2006102645A1 Biaryl derived amide modulators of vanilloid vr1 receptor
09/28/2006CA2602583A1 Biaryl derived amide modulators of vanilloid vr1 receptor
09/19/2006US7109347 Inhibitor is an amino acid linked to a thiazolidine or a pyrrolidine group by a peptide bond, e.g., L-threo-isoleucylpyrrolidine, L-allo-isoleucylthiazolidine, L-allo-isoleucylpyrrolydine, L-glutamoylthiazolidine, L-glutamoylpyrrolidine, L-glutamoythiazolidine, L-glutamoylpyrrolidine and their salts
09/12/2006US7105660 Intramolecular amidation of sulfamates catalyzed by metalloporphyrins
08/2006
08/31/2006WO2006074940A3 Macrocyclic compounds and compositions useful as bace inhibitors
1 2 3 4 5 6 7 8 9 10 11